ELTP Elite Pharmaceuticals, Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
11:17
Jan 14
Jan 14
ELTP insider exercise may signal buyout prep within 83 days
Author argues ELTP is a long because Executive VP Doug Plasche exercised 2.5 million more shares, which the author interprets as insider confidence and as possible preparation for an announced sale of the company. He notes a blackout period is coming and ties the timing to the CEO's end-of-fiscal-year target to identify the buyer, leaving roughly 83 days for the catalyst. The author frames the position as a moonshot alongside insiders who are fully vested and lined up.
HIGH
10:53
Jan 02
Jan 02
ELTP executive signals floor near $0.60; shares bargain at $0.50.
Elite Pharmaceuticals' executive share purchases near $0.59 and a large insider's partial sale at $0.58-$0.62 are interpreted as price floors, since the seller retained 3.5 million shares. The author values the stock at $2.60 to $4.80 based on market penetration, sales, and profit margins, and even a halved low estimate would imply $1.30-$1.40. At around $0.50 the shares are called an absolute bargain with an easy 20% return from the executive signals alone.
HIGH
About ELTP Investor Commentary
Across the available history and selected sources, Buzzberg tracks ELTP (Elite Pharmaceuticals, Inc.) across 1 sources: 2 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 2 total trade ideas tracked. Latest voices: u/Wolvshammy.